Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The colonic mucosa is the innermost layer of the large intestine, consisting of a simple columnar epithelium, the lamina propria, and the muscularis mucosae (StatPearls, Histology, Colon, 2023). The primary cell type within this layer is the enterocyte, which specializes in the absorption of water, electrolytes, and products of bacterial fermentation such as short-chain fatty acids (PubMed, PMID: 28607316). Beyond absorption, the colonic mucosa serves as a vital semi-permeable barrier that protects the body from luminal pathogens and toxins while facilitating immune tolerance (Nature Reviews Gastroenterology & Hepatology, 2017). Pathological changes in the colonic mucosa and enterocyte function are hallmarks of diseases such as ulcerative colitis and Crohn's disease, where the barrier is compromised and immune infiltration occurs (NIH, NIDDK, 2020). Although "Colonic mucosa and enterocytes" refers to a tissue and cell type rather than a single molecular target, it is the primary site for the delivery and action of many gastrointestinal therapies, including aminosalicylates and site-specific corticosteroids (PubChem, CID: 4075).
Pharmacological agents do not target the colonic mucosa as a single molecule; instead, they modulate various pathways within the mucosal environment. For example, 5-aminosalicylates provide local anti-inflammatory effects, while biologics like vedolizumab target specific integrins to prevent lymphocyte homing to the colonic mucosa (PubChem, CID: 4075; Nature Reviews Gastroenterology & Hepatology, 2017).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic mucosa and enterocytes.